Protara Therapeutics
TARA
TARA
31 hedge funds and large institutions have $8.55M invested in Protara Therapeutics in 2023 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 3 increasing their positions, 9 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
67% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 9
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $2K
Holders
31
Holding in Top 10
–
Calls
–
Puts
$2K
Top Buyers
| 1 | +$80.1K | |
| 2 | +$27.8K | |
| 3 | +$5.92K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$277 |
| 5 |
JP Morgan Chase
New York
|
+$25 |
Top Sellers
| 1 | -$53.8K | |
| 2 | -$30.3K | |
| 3 | -$17K | |
| 4 |
Millennium Management
New York
|
-$14.9K |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
-$11.3K |